Cilazapril to lisinopril dose conversion

Size: px
Start display at page:

Download "Cilazapril to lisinopril dose conversion"

Transcription

1 Cilazapril to lisinopril dose conversion The Borg System is 100 % Cilazapril to lisinopril dose conversion COMPARISON OF ANGIOTENSIN CONVERTING ENZYME (ACE). INHIBITORS. Drug. Approximate. Dose. Equivalence. Maximum daily dose (mg/day). Once Daily. Dosing. Captopril1. (Capoten ) mg tid No. Enalapril maleate. ( Vasotec)2. Enalapril sodium2. 5 mg daily. 4 mg daily. 40. Yes. Ramipril1. (Altace ). Calculation of equivalent doses of antihypertensive drugs. β-blocker. - Select active agent 1 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent 2 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent -, Metoprolol, Atenolol, Bisoprolol, Nebivolol. Mar 10, Common Medication Conversions (Equivalents). Ace Inhibitors. Drug Comparisons - Home Page. Select the target ACE- Inhibitor, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, ramipril. Reference. Dana S, Marasco RA, Sengson S. Outcomes Based Therapeutic Interchange: An. Dec 9, :7.5 is suggested for the treatment of raised blood pressure. Equivalent dosing, as indicated in the above table, is difficult as captopril should not be used as a once daily medication. Average daily doses for each of the ACE inhibitors are captopril 37.5 mg. = lisinopril 10mg = enalapril 5mg = quinapril 10mg. Drug, Comparable dose based on therapeutic interchange studies, comparative clinical studies, and manufacturer's recommended dosing for hypertension, Drug. Enalapril (Vasotec), 2.5mg daily, 5mg daily, 10mg daily or 5mg twice daily, 20mg daily or 10mg twice daily, 40mg daily or 20mg twice daily, Eprosartan. 45%), short-term lisinopril resulted in dose-dependent reductions in aldoste- rone and endothelin levels in patients on 20 mg of lisinopril compared with 5 mg daily.21 In severe HF, however, dose dependency of angiotensin II was not evident, as demonstrated in a study using enalapril.22. It should be noted, however, that. weeks after each dosage adjustment.

2 Signature. Lisinopril 10 mg. Enalapril 5 mg (Optimal 20 mg). Moexipril 7.5 mg. Enalapril 5 mg (Optimal 20 mg). Quinapril 10 mg. Enalapril 5 mg (Optimal 20 mg). Trandolapril 1 mg. Doses listed are representative of equivalent doses and should be used to calculate other doses. Switching Ace-inhibitors switching_ace_inhibitors.html. Change to. Change from. Enalapril. (Once daily dosing). Quinapril. Lisinopril. Lisinopril 5mg daily. Enalapril 5mg. Quinapril 5mg. Ramipril 1.25mg. Lisinopril 10mg daily. Enalapril 10mg. Quinapril 10mg. Ramipril 2.5mg. Jan 11, patients) is an angiotensin-converting enzyme inhibitor (ACE inhibitor, ACEI), or an angiotensin-ii receptor inhibiting the conversion of angiotensin I to II.... Enalapril 20mg. Lisinopril 10mg. Valsartan 160mg. Losartan 100mg. Olmesartan > Candesartan > Losartan. Valsartan > Telmisartan > Losartan. Biphosphonates : liste des médicaments suivant la classification pharmacothérapeutique VIDAL. Finalised in 2006 Finalised in 2007 Finalised in 2008 Finalised in 2009 Finalised in 2010 Finalised in 2011 Finalised in 2012 Finalised in 2013 Finalised in Type de médicament. Utilité. Principaux produits. Quand les prendre? Nitrates. Traitement de l angine puisqu ils dilatent les vaisseaux sanguins. An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. Los receptores AT2 sólo predominan y se manifiestan en la vida intrauterina y en las primeras semanas de vida extrauterina. Sistema calicreína-cinina Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors.it is used for essential (primary) hypertension. While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit. Définition, classification OMS, facteurs de risques, hygiène de vie, HTA et grossesse, auto mesure. Il metoprololo tartrato è un principio attivo appartenente alla categoria dei bloccanti beta-adrenergici, ad attività beta1-selettiva. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada; Search for more papers by this author. farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase). weeks after each dosage adjustment. Signature. Lisinopril 10 mg. Enalapril 5 mg

3 (Optimal 20 mg). Moexipril 7.5 mg. Enalapril 5 mg (Optimal 20 mg). Quinapril 10 mg. Enalapril 5 mg (Optimal 20 mg). Trandolapril 1 mg. Doses listed are representative of equivalent doses and should be used to calculate other doses. Jan 11, patients) is an angiotensin-converting enzyme inhibitor (ACE inhibitor, ACEI), or an angiotensin-ii receptor inhibiting the conversion of angiotensin I to II.... Enalapril 20mg. Lisinopril 10mg. Valsartan 160mg. Losartan 100mg. Olmesartan > Candesartan > Losartan. Valsartan > Telmisartan > Losartan. Calculation of equivalent doses of antihypertensive drugs. β-blocker. - Select active agent 1 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent 2 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent -, Metoprolol, Atenolol, Bisoprolol, Nebivolol. Switching Ace-inhibitors switching_ace_inhibitors.html. Change to. Change from. Enalapril. (Once daily dosing). Quinapril. Lisinopril. Lisinopril 5mg daily. Enalapril 5mg. Quinapril 5mg. Ramipril 1.25mg. Lisinopril 10mg daily. Enalapril 10mg. Quinapril 10mg. Ramipril 2.5mg. Drug, Comparable dose based on therapeutic interchange studies, comparative clinical studies, and manufacturer's recommended dosing for hypertension, Drug. Enalapril (Vasotec), 2.5mg daily, 5mg daily, 10mg daily or 5mg twice daily, 20mg daily or 10mg twice daily, 40mg daily or 20mg twice daily, Eprosartan. COMPARISON OF ANGIOTENSIN CONVERTING ENZYME (ACE). INHIBITORS. Drug. Approximate. Dose. Equivalence. Maximum daily dose (mg/day). Once Daily. Dosing. Captopril1. (Capoten ) mg tid No. Enalapril maleate. ( Vasotec)2. Enalapril sodium2. 5 mg daily. 4 mg daily. 40. Yes. Ramipril1. (Altace ). Mar 10, Common Medication Conversions (Equivalents). Ace Inhibitors. Drug Comparisons - Home Page. Select the target ACE-Inhibitor, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, ramipril. Reference. Dana S, Marasco RA, Sengson S. Outcomes Based Therapeutic Interchange: An. 45%), short-term lisinopril resulted in dose-dependent reductions in aldoste- rone and endothelin levels in patients on 20 mg of lisinopril compared with 5 mg daily.21 In severe HF, however, dose dependency of angiotensin II was not evident, as demonstrated in a study using enalapril.22. It should be noted, however, that. Dec 9, :7.5 is suggested for the treatment of raised blood pressure. Equivalent dosing, as indicated in the above table, is

4 difficult as captopril should not be used as a once daily medication. Average daily doses for each of the ACE inhibitors are captopril 37.5 mg. = lisinopril 10mg = enalapril 5mg = quinapril 10mg. farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase). Los receptores AT2 sólo predominan y se manifiestan en la vida intrauterina y en las primeras semanas de vida extrauterina. Sistema calicreína-cinina University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada; Search for more papers by this author. Type de médicament. Utilité. Principaux produits. Quand les prendre? Nitrates. Traitement de l angine puisqu ils dilatent les vaisseaux sanguins. Biphosphonates : liste des médicaments suivant la classification pharmacothérapeutique VIDAL. Il metoprololo tartrato è un principio attivo appartenente alla categoria dei bloccanti beta-adrenergici, ad attività beta1- selettiva. Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors.it is used for essential (primary) hypertension. While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit. An angiotensinconverting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. Définition, classification OMS, facteurs de risques, hygiène de vie, HTA et grossesse, auto mesure. Finalised in 2006 Finalised in 2007 Finalised in 2008 Finalised in 2009 Finalised in 2010 Finalised in 2011 Finalised in 2012 Finalised in 2013 Finalised in Drug, Comparable dose based on therapeutic interchange studies, comparative clinical studies, and manufacturer's recommended dosing for hypertension, Drug. Enalapril (Vasotec), 2.5mg daily, 5mg daily, 10mg daily or 5mg twice daily, 20mg daily or 10mg twice daily, 40mg daily or 20mg twice daily, Eprosartan. Jan 11, patients) is an angiotensin-converting enzyme inhibitor (ACE inhibitor, ACEI), or an angiotensin-ii receptor inhibiting the conversion of angiotensin I to II.... Enalapril 20mg. Lisinopril 10mg. Valsartan 160mg. Losartan 100mg. Olmesartan > Candesartan > Losartan. Valsartan > Telmisartan > Losartan. weeks after each dosage adjustment. Signature. Lisinopril 10 mg. Enalapril 5 mg (Optimal 20 mg). Moexipril 7.5 mg. Enalapril 5 mg (Optimal 20 mg). Quinapril 10 mg. Enalapril 5 mg (Optimal 20 mg). Trandolapril 1 mg. Doses listed are representative of

5 equivalent doses and should be used to calculate other doses. Calculation of equivalent doses of antihypertensive drugs. β-blocker. - Select active agent 1 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent 2 -, Metoprolol, Atenolol, Bisoprolol, Nebivolol, Propranolol, Sotalol. - Select active agent -, Metoprolol, Atenolol, Bisoprolol, Nebivolol. 45%), shortterm lisinopril resulted in dose-dependent reductions in aldoste- rone and endothelin levels in patients on 20 mg of lisinopril compared with 5 mg daily.21 In severe HF, however, dose dependency of angiotensin II was not evident, as demonstrated in a study using enalapril.22. It should be noted, however, that. Switching Ace-inhibitors switching_ace_inhibitors.html. Change to. Change from. Enalapril. (Once daily dosing). Quinapril. Lisinopril. Lisinopril 5mg daily. Enalapril 5mg. Quinapril 5mg. Ramipril 1.25mg. Lisinopril 10mg daily. Enalapril 10mg. Quinapril 10mg. Ramipril 2.5mg. COMPARISON OF ANGIOTENSIN CONVERTING ENZYME (ACE). INHIBITORS. Drug. Approximate. Dose. Equivalence. Maximum daily dose (mg/day). Once Daily. Dosing. Captopril1. (Capoten ) mg tid No. Enalapril maleate. ( Vasotec)2. Enalapril sodium2. 5 mg daily. 4 mg daily. 40. Yes. Ramipril1. (Altace ). Dec 9, :7.5 is suggested for the treatment of raised blood pressure. Equivalent dosing, as indicated in the above table, is difficult as captopril should not be used as a once daily medication. Average daily doses for each of the ACE inhibitors are captopril 37.5 mg. = lisinopril 10mg = enalapril 5mg = quinapril 10mg. Mar 10, Common Medication Conversions (Equivalents). Ace Inhibitors. Drug Comparisons - Home Page. Select the target ACE- Inhibitor, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, ramipril. Reference. Dana S, Marasco RA, Sengson S. Outcomes Based Therapeutic Interchange: An. Type de médicament. Utilité. Principaux produits. Quand les prendre? Nitrates. Traitement de l angine puisqu ils dilatent les vaisseaux sanguins. Biphosphonates : liste des médicaments suivant la classification pharmacothérapeutique VIDAL. An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. Finalised in 2006 Finalised in 2007 Finalised in 2008 Finalised in 2009 Finalised in 2010 Finalised in 2011 Finalised in 2012 Finalised in 2013 Finalised in farnesyl diphosphate synthase (farnesyl pyrophosphate

6 synthetase, dimethylallyltranstransferase, geranyltranstransferase). Définition, classification OMS, facteurs de risques, hygiène de vie, HTA et grossesse, auto mesure. Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors.it is used for essential (primary) hypertension. While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada; Search for more papers by this author. Il metoprololo tartrato è un principio attivo appartenente alla categoria dei bloccanti beta-adrenergici, ad attività beta1-selettiva. Los receptores AT2 sólo predominan y se manifiestan en la vida intrauterina y en las primeras semanas de vida extrauterina. Sistema calicreína-cinina Contact Information Telephone or BORG (2674) FAX Postal address Minnetonka Industrial Rd. Minnetonka, MN Electronic mail General Information: thin soft stool, back pain\ Credit report repair software Sitemap Thursday, July 29, 1999 This Site Has Been Visited Times.

Conversion of losartan to lisinopril

Conversion of losartan to lisinopril Cari untuk: Cari Cari Conversion of losartan to lisinopril Dania Alsammarae, Strategy Director and co-founder of Anglo Arabian Healthcare speaks with Neil Halligan of Arabian Business on what it takes

More information

Lisinopril losartan conversion dose

Lisinopril losartan conversion dose P ford residence southampton, ny Lisinopril losartan conversion dose Deep in-house technology, streaming expertise, and partnerships with the widest range of digital platforms secures our position as the

More information

Losartan lisinopril equivalent dose 新着 news 2018 年 3 月 6 日高等部 3 年生 大阪リゾート & スポーツ専門学校に合格! 2018 年 3 月 2 日茨木市立山手台小学校との交流.

Losartan lisinopril equivalent dose 新着 news 2018 年 3 月 6 日高等部 3 年生 大阪リゾート & スポーツ専門学校に合格! 2018 年 3 月 2 日茨木市立山手台小学校との交流. P ford residence southampton, ny Losartan lisinopril equivalent dose 新着 news 2018 年 3 月 6 日高等部 3 年生 大阪リゾート & スポーツ専門学校に合格! 2018 年 3 月 2 日茨木市立山手台小学校との交流. Losartan is classified as FDA pregnancy risk category

More information

Losartan lisinopril equivalent dose

Losartan lisinopril equivalent dose 新着 news 2018 年 2 月 28 日 jica 国際協力中学生 高校生エッセイコンテスト 2017 表彰式 2018 年 2 月 19 日 2017 年度第 8 回卒業式を挙行. CHFpatients.com - Ace inhibitors explained in plain English - the primary drug treatment for heart failure

More information

Lisinopril 20 converting to losartan

Lisinopril 20 converting to losartan Search Lisinopril 20 converting to losartan Stop wasting your time with unanswered searches. lisinopril 40 mg to losartan conversion,cannot Find low price Best. Winds SSW at 10 to 20. Lisinopril 20 to

More information

Trandolapril to lisinopril

Trandolapril to lisinopril Trandolapril to lisinopril Lisinopril : learn about side effects, dosage, special precautions, and more on MedlinePlus. Tansiyon, hipertansiyon ilaçlarını; antihipertansif ilaçları içerir.. Tansiyon -

More information

ASEBP and ARTA TARP Drugs and Reference Price by Categories

ASEBP and ARTA TARP Drugs and Reference Price by Categories ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole

More information

Lisinopril to losartan equivalent

Lisinopril to losartan equivalent Your browser does not support script 22-11-2011 Specifically, Lisinopril (brand names include Prinivil and Zestril) is the third most-prescribed drug in the US, according to WebMD Health News (April 20.

More information

Ace to arb conversion

Ace to arb conversion Ace to arb conversion inhibitors (ACEI) and angiotensin receptor blockers (ARB) doses on outcomes in patients.. angiotensin-converting enzyme inhibitors, ACE inhibi- tors, ACEI. Aug 22, 2014. Angiotensin

More information

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation Annex I Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed explanation of the scientific grounds for the differences from the PRAC recommendation 1

More information

Brookings Roundtable on Active Medical Product Surveillance:

Brookings Roundtable on Active Medical Product Surveillance: 2012, The Brookings Institution Brookings Roundtable on Active Medical Product Surveillance: Findings from a Mini-Sentinel Medical Product Assessment Marsha Reichman, U.S. Food and Drug Administration

More information

Factors Involved in Poor Control of Risk Factors

Factors Involved in Poor Control of Risk Factors Factors Involved in Poor Control of Risk Factors Patient compliance Clinical inertia Health Care System structure 14781 M Limitations of Formal Studies Selection of patients Recruitment and follow-up alter

More information

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation Annex I Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed explanation of the scientific grounds for the differences from the PRAC recommendation 1

More information

Clinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18

Clinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18 Clinical Policy: Reference Number: CP.PMN.61 Effective Date: 08.01.14 Last Review Date: 05.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre

Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document

More information

ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease

ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease Is This Guide Right for Me? This Guide Is for You If: You have coronary heart disease,

More information

Annual Review of Antihypertensives - Fiscal Year 2009

Annual Review of Antihypertensives - Fiscal Year 2009 Annual Review of Antihypertensives - Fiscal Year 2009 Oklahoma HealthCare Authority April 2010 Current Prior Authorization Criteria There are 7 categories of antihypertensive medications currently included

More information

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series At Risk Population: Measure 33 Coronary Artery Disease (CAD-7): Angiotensin-Converting Enzyme (ACE) Inhibitor

More information

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:

More information

Cardiac Medications At A Glance

Cardiac Medications At A Glance Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)

More information

Amlodipine/olmesartan (Azor ) is indicated for the treatment of hypertension, alone or in combination with other antihypertensive medications.

Amlodipine/olmesartan (Azor ) is indicated for the treatment of hypertension, alone or in combination with other antihypertensive medications. Page 1 of 8 Policies Repository Policy Title Policy Number Oral Antihypertensive Agents FS.CLIN.9 Application of Pharmacy Policy is determined by benefits and contracts. Benefits may vary based on product

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 7 January 2009

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 7 January 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 7 January 2009 LERCAPRESS 10 mg/10 mg, film-coated tablets Pack of 30 (CIP code: 385 953-3) Pack of 90 (CIP code:

More information

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting

More information

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 9/11/2018 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 5/17, 9/15, 2/13, 2/08, LOB

More information

Entresto Development of sacubitril/valsartan (LCZ696) for the treatment of heart failure with reduced ejection fraction

Entresto Development of sacubitril/valsartan (LCZ696) for the treatment of heart failure with reduced ejection fraction Cardio-Metabolic Franchise Entresto Development of sacubitril/valsartan (LCZ696) for the treatment of heart failure with reduced ejection fraction Randy L Webb, PhD Rutgers Workshop October 21, 2016 Heart

More information

Florida Blue QUALITY PERFORMANCE METRIC STANDARDS FEBRUARY 2013

Florida Blue QUALITY PERFORMANCE METRIC STANDARDS FEBRUARY 2013 Florida Blue QUALITY PERFORMANCE METRIC STANDARDS FEBRUARY 2013 QUALITY PERFORMANCE METRIC CALCULATION QUALITY METRICS SELECTED FOR MEASUREMENT Per Section 3.2 of the Agreement, HCPP must meet the following

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,

More information

State of the art treatment of hypertension: established and new drugs. Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland

State of the art treatment of hypertension: established and new drugs. Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland State of the art treatment of hypertension: established and new drugs Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland First line therapies in hypertension ACE inhibitors AT

More information

HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS )

HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS ) STARS MEASURES 2015 HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS ) Developed by the National Committee for Quality Assurance (NCQA), HEDIS is the most widely used set of performance measures

More information

Ace to arb conversion dose

Ace to arb conversion dose Ace to arb conversion dose 11/24/2017 Masha babko image venue 11/26/2017 Unblocked cs go surfing 11/28/2017 -Luke garrett disease -Bokachoda bengali 11/29/2017 Dropbox link virus 12/01/2017 Bazzars in

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 27 May 2009 RASILEZ HCT 150 mg/12.5 mg, film-coated tablets B/30 (CIP code: 392 151-6) RASILEZ HCT 150 mg/25 mg, film-coated

More information

Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic

Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic June Chen 1, Charlotte Galenza 1, Justin Ezekowitz 2,3,

More information

Guide to the Modernized Reference Drug Program

Guide to the Modernized Reference Drug Program Guide to the Modernized Reference Drug Program For prescribers and pharmacists Medical Beneficiary and Pharmaceutical Services Division June 1, 2016 Contents 1 Introduction 1 2 About this Guide 2 3 About

More information

Guideline-Directed Medical Therapy

Guideline-Directed Medical Therapy Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in

More information

Hypertension (JNC-8)

Hypertension (JNC-8) Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint

More information

CONCORD INTERNAL & PULMONARY MEDICINE CONGESTIVE HEART FAILURE PROTOCOL. Douglas G. Kelling, Jr., MD & C. Gismondi-Eagan, MD, FACP

CONCORD INTERNAL & PULMONARY MEDICINE CONGESTIVE HEART FAILURE PROTOCOL. Douglas G. Kelling, Jr., MD & C. Gismondi-Eagan, MD, FACP CONCORD INTERNAL & PULMONARY MEDICINE CONGESTIVE HEART FAILURE PROTOCOL Douglas G. Kelling, Jr., MD & C. Gismondi-Eagan, MD, FACP Revised August 14, 2009 Page 1 Congestive Heart Failure Protocol Patients

More information

8/19/2016. No Conflicts. I struggled with everything cardiac in nursing school.

8/19/2016. No Conflicts. I struggled with everything cardiac in nursing school. Cindy Weston, DNP, RN, CCRN, CNS CC, FNP BC Assistant Professor, Texas A&M Health Science Center College of Nursing Describe and define epidemiology and pathophysiology of hypertension Differentiate JNC8

More information

Clinical Teach-Back Cards

Clinical Teach-Back Cards Clinical Teach-Back Cards The Medicare Quality Improvement Organization for Texas TMF Health Quality Institute focuses on improving lives by improving the quality of health care through contracts with

More information

Don t let the pressure get to you:

Don t let the pressure get to you: Balanced information for better care Don t let the pressure get to you: Current evidence-based goals for treating hypertension A cornerstone of primary care: Lowering high blood pressure prevents cardiovascular

More information

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN

More information

Study Exposures, Outcomes:

Study Exposures, Outcomes: GSK Medicine: Coreg IR, Coreg CR, and InnoPran Study No.: WWE111944/WEUSRTP3149 Title: A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic

More information

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical

More information

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER) MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB

More information

Blood pressure control. Rok Humar, PhD Department of Research

Blood pressure control. Rok Humar, PhD Department of Research Blood pressure control Rok Humar, PhD Department of Research Mean arterial blood pressure is determined by Blood volume Cardiac output Peripheral resistance Blood capacitance Resistance of the system to

More information

ISMJ International SportMed Journal

ISMJ International SportMed Journal 32 ISMJ International SportMed Journal FIMS Position Statement Antihypertensive medications and exercise Associate Professor Wayne Derman UCT/MRC Research Unit for Exercise Science and Sports Medicine,

More information

Hypertension is also an important risk factor in the development of chronic kidney disease and heart failure.

Hypertension is also an important risk factor in the development of chronic kidney disease and heart failure. Hypertension Hypertension Hypertension is defined as either a sustained systolic blood pressure of greater than 140 mm Hg or a sustained diastolic blood pressure of greater than 90 mm Hg. Hypertension

More information

Don t let the pressure get to you:

Don t let the pressure get to you: Balanced information for better care Don t let the pressure get to you: An update on the changing recommendations for treating hypertension New trial data and guidelines have made hypertension care more

More information

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC Pharmacotherapy of HTN Rationale for reducing arterial pressure Reduce cardiac output Reduce heart rate Reduce stroke

More information

Select Preventive Prescription Drugs Jan. 1, 2018

Select Preventive Prescription Drugs Jan. 1, 2018 Select Preventive Prescription Drugs Jan. 1, 2018 In addition to a healthy lifestyle, preventive medications can help you avoid some illnesses and conditions. Zimmer Biomet's medical options Value HSA,

More information

Medications for Type 2 Diabetes CDE Exam Preparation

Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Agenda Medication

More information

Clinical Teach-Back Cards

Clinical Teach-Back Cards Clinical Teach-Back Cards The Quality Innovation Network - Quality Improvement Organization (QIN-QIO) for Delaware, Louisiana, New Jersey, Pennsylvania and West Virginia The people at Quality Insights

More information

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition.

More information

The ADDITION Study: A study about screening for diabetes. Screening Case Report Form

The ADDITION Study: A study about screening for diabetes. Screening Case Report Form ADDITION Study, Leicester Participant Identification Label: Date: / / The ADDITION Study: A study about screening for diabetes Screening Case Report Form You will need to have the following things done

More information

Physician/Clinic Collaborative Practice Agreement

Physician/Clinic Collaborative Practice Agreement Physician/Clinic Collaborative Practice Agreement Effective October 1, 2010, Connecticut Senate Bill 428 (PA 10-117) extends to all settings and medical conditions the opportunity for licensed pharmacists

More information

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40% Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF

More information

Clinical Policy: Angiotesin II Receptor Blockers and Renin Inhibitors Reference Number: CP.HNMC.15 Effective Date: Last Review Date: 08.

Clinical Policy: Angiotesin II Receptor Blockers and Renin Inhibitors Reference Number: CP.HNMC.15 Effective Date: Last Review Date: 08. Clinical Policy: Reference Number: CP.HNMC.15 Effective Date: 11.16.16 Last Review Date: 08.17 Revision Log Line of Business: Medicaid Medi-Cal See Important Reminder at the end of this policy for important

More information

Common Drug Review Pharmacoeconomic Review Report

Common Drug Review Pharmacoeconomic Review Report Common Drug Review Pharmacoeconomic Review Report June 2017 Drug Ivabradine hydrochloride (Lancora) Indication For the treatment of stable chronic heart failure with reduced left ventricular ejection fraction

More information

4/3/2014 OBJECTIVES BLOOD PRESSURE BASICS. Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7

4/3/2014 OBJECTIVES BLOOD PRESSURE BASICS. Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7 1 OBJECTIVES Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7 Review mechanisms for the main drug classes used to treat hypertension Describe the dosing strategies

More information

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided

More information

Living with Congestive Heart Failure: A Guide to a Healthy Heart

Living with Congestive Heart Failure: A Guide to a Healthy Heart Living with Congestive Heart Failure: A Guide to a Healthy Heart Things to Know, Before You Go Dear Patient/Caregiver These are the things you NEED TO KNOW, BEFORE YOU GO. It is very important that you

More information

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR.

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR. ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR. CRAIG STERN, PHARMD, MBA, RPH, FASCP, FASHP, FICA, FLMI, FAMCP RENIN-ANGIOTENSIN

More information

Objectives. Outline 4/3/2014

Objectives. Outline 4/3/2014 Jessica Litke PGY1 ISHP Spring Meeting April 12, 2014 Objectives Appreciate the significance of heart failure (HF) to a patient and to the health care system Understand 2013 ACCF/AHA guidelines for the

More information

What in the World is Functional Medicine?

What in the World is Functional Medicine? What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They

More information

PassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC

PassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC Medication Review Cardiovascular Drugs Pharmacy Technician Training Systems Passassured, LLC p1 Medication Review, Cardiovascular Drugs Click Here for Glossary Index! Click Here to Print Topic Help File

More information

Generic Preventive Care/ Safe Harbor Drug Program List

Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition. The Generic Preventive Care/Safe Harbor Drug Program

More information

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERECE CARDS Chronic Kidney Disease CKD VA/DoD Clinical Practice Guideline for the Management

More information

Drug Class Review on Angiotensin Converting Enzyme Inhibitors

Drug Class Review on Angiotensin Converting Enzyme Inhibitors Drug Class Review on Angiotensin Converting Enzyme Inhibitors UPDATED FINAL REPORT #1 April 2004 Roger Chou, MD Mark Helfand, MD, MPH Susan Carson, MPH Oregon Evidence-based Practice Center Oregon Health

More information

Benazepril to losartan conversion

Benazepril to losartan conversion Benazepril to losartan conversion 01/09/2018 Branches of language 01/10/2018 Dr oz show todays episode on tea 01/11/2018 -Livetheorangelife.com>pay & award >orange awards. -Water park oops! 01/12/2018

More information

Ace inhibitors equivalent dosing

Ace inhibitors equivalent dosing Ace inhibitors equivalent dosing Jan 11, 2008. No information on dosing equivalents of ACE Inhibitors and AIIAs is available. If changing a inhibiting the conversion of angiotensin I to II. ACE Inhibitor

More information

Codes for a Medicare claims-based model to predict LVEF class- User Guide

Codes for a Medicare claims-based model to predict LVEF class- User Guide Description and citation: This guide accompanies our manuscript [Desai RJ, Lin KJ, Patorno E, et al. Development and Preliminary Validation of a Medicare Claims Based Model to Predict Left Ventricular

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Instructions and Checklist for Your Heart Procedure

Instructions and Checklist for Your Heart Procedure PATIENT EDUCATION Instructions and Checklist for Your Heart Procedure allinahealth.org 2016 ALLINA HEALTH SYSTEM. TM A TRADEMARK OF ALLINA HEALTH SYSTEM. OTHER TRADEMARKS USED ARE OWNED BY THEIR RESPECTIVE

More information

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure? Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,

More information

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut ANTIHYPERTENSIVES Assoc. Prof. Bilgen Başgut Hypertension Hypertension is a condition in which the blood pressure is persistently higher than normal Hypertension > 140 mmhg > 90 mmhg Systolic Blood Pressure

More information

Hypertension Management - Summary

Hypertension Management - Summary Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)

More information

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important? Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?,FACA,FICA,MASH,FVBWG,MISCP CONSULTANT OF CARDIOLOGY DIRECTOR OF PORT-FOUAD HOSPITAL CCU Consideration of antihypertensive agents

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

Guidelines for the Prescribing of Sacubitril / Valsartan

Guidelines for the Prescribing of Sacubitril / Valsartan Hull & East Riding Prescribing Committee Guidelines for the Prescribing of Sacubitril / Valsartan 1. BACKGROUND Sacubitril valsartan is an angiotensin receptor neprilysin inhibitor, including both a neprilysin

More information

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs What is Hypertension: A common, incurable, persistent, but usually

More information

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Information in these slides is used with permission from St. Mary s Cardiac Rehab Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix Should Diabetes Mellitus be a Compelling Indication for Renin Angiotensin System Blockers? Insights from a Systematic Review and Meta-Analysis of Randomized Trials Sripal Bangalore,

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

Section 3, Lecture 2

Section 3, Lecture 2 59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect

More information

HEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.

HEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment. HEART FAILURE SUMMARY + Heart Failure is a condition affecting a large number of Irish people and is associated with significant morbidity and mortality. + ACE inhibitors, in combination with diuretics,

More information

REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.

REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. CARDIOMYOPATHY REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. * REQUEST FOR ANGIO-TENSIN RECEPTOR BLOCKER WILL REQUIRE

More information

Drum Up Support. Living with Heart Failure. Doctor. Phone number. Emergency number. Target weight

Drum Up Support. Living with Heart Failure. Doctor. Phone number. Emergency number. Target weight Drum Up Support Regular doctor visits help drum up support in your favor! Living with Heart Failure Doctor Phone number Emergency number Target weight This material originated with the Arkansas Foundation

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Class Update: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs), and Direct Renin Inhibitors (DRIs)

Class Update: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs), and Direct Renin Inhibitors (DRIs) Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Class Update: Angiotensin-Converting Enzyme Inhibitors

More information

Drug Use Criteria: Angiotensin-Converting Enzyme Inhibitors

Drug Use Criteria: Angiotensin-Converting Enzyme Inhibitors Texas Vendor Program Use Criteria: Angiotensin-Converting Enzyme Inhibitors Publication History Developed June 1996. Revised December 2016; December 2014; March 2013; April 2011; March 2011; April 2008;

More information

C o n t i n u i n g E d u c a t i o n

C o n t i n u i n g E d u c a t i o n C o n t i n u i n g E d u c a t i o n tech talkce the national continuing education program for pharmacy technicians 1 CEU Answer online for instant results www.pharmacygateway.ca February/March 2008 Approved

More information

Metoprolol to diltiazem conversion table

Metoprolol to diltiazem conversion table Metoprolol to diltiazem conversion table The Borg System is 100 % Metoprolol to diltiazem conversion table 10/31/2017 What escape planning factors can facilitate or hinder your. 10/31/2017 Corporate buzzwords

More information

LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group

LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY 2016 (last updated July 28, 2016) Prepared by the Long-Term Care Medications Management Working Group Drug Classes for Consideration Angiotensin Converting

More information

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 The most important reason for treating hypertension in primary care is to prevent

More information

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100 Hypertension 1 Definition Hypertension can be defined as a condition where blood pressure is elevated to an extent that clinical benefit is obtained from blood pressure lowering. it is an important risk

More information

Metolazone to lasix conversion

Metolazone to lasix conversion Search Search Metolazone to lasix conversion Buy Viagra Online! Cheap Viagra Pills Online. 25mg, 50mg, 100mg tablets available today. Lowest Prices. Available with free Delivery & overnight shipping! Licensed.

More information

Heart Failure (HF): Scope of the Problem. Temporal Trends in Age-Adjusted Survival After HF Diagnosis. More malignant than most cancers

Heart Failure (HF): Scope of the Problem. Temporal Trends in Age-Adjusted Survival After HF Diagnosis. More malignant than most cancers Patients in US (millions) Heart Failure (HF): Scope of the Problem 1 4 2 3.5 4. 1. 1991 21 237 US prevalence*: 5. million US annual incidence: 7, Annual mortality: 22,754 5-1% depending on severity Cost:

More information